scispace - formally typeset
P

Pallu Reddanna

Researcher at University of Hyderabad

Publications -  196
Citations -  6655

Pallu Reddanna is an academic researcher from University of Hyderabad. The author has contributed to research in topics: Arachidonic acid & Lipoxygenase. The author has an hindex of 43, co-authored 190 publications receiving 5909 citations. Previous affiliations of Pallu Reddanna include Sri Venkateswara University & Yahoo!.

Papers
More filters
Journal ArticleDOI

Functional characterization of genetic enzyme variations in human lipoxygenases

TL;DR: It is found that there appears to be an evolutionary pressure on the coding regions of the lipoxygenase genes preventing the accumulation of loss-of-function variations in the human population.
Journal ArticleDOI

C-Phycocyanin inhibits 2-acetylaminofluorene-induced expression of MDR1 in mouse macrophage cells: ROS mediated pathway determined via combination of experimental and In silico analysis

TL;DR: C-PC was more effective in reduction of MDR1 expression than inhibitors of NADPH oxidase and Akt, and the ROS levels determined through In silico investigation showed that C-PC's usefulness in overcoming the drug resistance in cellular systems is suggested.
Journal ArticleDOI

Genetic variants of thiopurine and folate metabolic pathways determine 6-MP-mediated hematological toxicity in childhood ALL

TL;DR: Gene-gene interaction between thiopurine and folate pathways inflate the 6-mercaptopurine-mediated toxicity in Indian children with ALL illustrating the importance of ethnicity in the toxicity of 6-MP.
Journal ArticleDOI

Serum lipid peroxides and lipids in urban and rural Indian men.

TL;DR: The marked elevation of lipid peroxides and lipids in urban men may be the result of urbanization, including exposure to environmental pollutants.
Journal ArticleDOI

Potential Therapeutic Applications of C-Phycocyanin.

TL;DR: The data from various studies suggest the therapeutic applications of C-PC such as anti-cancer activity, anti-inflammation,Anti-angiogenic activity and healing capacity of certain autoimmune disorders.